Searched for
SERUM LIFE SCIENCES
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...
- Poonawalla's clear shot at access for all via route socialCyrus S Poonawalla, chairman of Serum Institute of India, has created a legacy where business and social impact go hand in hand. His vaccin...
- Serum CEO acquires London house in year's 'biggest' dealAccording to sources quoted by the newspaper, while the Poonawalla family did not intend to relocate, the mansion would "serve as a base fo...
- Adar Poonawalla to buy London property for Rs 1,440 crore, the second-most expensive ever soldIndian billionaire Adar Poonawalla is set to purchase a London mansion, Aberconway House, for £138 million (Rs 1,440 crore), marking the ci...
- Natasha Poonawalla's Diwali a starry-sequinned-shimmery one, starring Rishi Sunak and Priyanka Chopra!The Chairperson of Serum Life Sciences UK thanked Sunak for the growing support and encouragement.
- Serum Institute to double investment in Biocon Biologics to $300 millionSerum Institute of Life Sciences (SILS) has converted a $150 million loan into equity, increasing its investment in Biocon Biologics. This ...
- Serum Life Sciences to double investments in Biocon Biologics to $300 million under new arrangementUnder the fresh terms of their strategic alliance, Serum Life Sciences will make an additional equity investment of $150 million through th...
- India's Serum to double investment in Biocon's unit to $300 mlnSerum Institute of Life Sciences is a unit of Serum Institute of India, the world's biggest vaccine maker. Under new terms of the alliance,...
- Natasha Poonawalla’s candy dress draws mixed reactions, check out hereNatasha Poonawalla shares a post where she’s dressed in a red and white puffer coat couture gown by designer label Moncler. Bollywood celeb...
- CCI clears Serum Institute Life Sciences-Biocon Biologics dealOnce the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about 15 per cent stake in Biocon Biologics Ltd, according to th...
- Wockhardt unit partners with SII subsidiary to set up vaccine manufacturing plant in UKThe collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable number of employment opportunities al...
- Wockhardt, Serum enter pact to do fill-finish of vaccinesWockhardt UK has manufactured a COVID-19 vaccine in collaboration with UK Government and AstraZeneca. Its collaboration with Serum Life Sci...
- Oxford University to get Poonawala vaccine research facility; to get GBP 50 million fundingSerum Life Sciences is wholly-owned by the Poonawalla family, owners of the Adar Poonawalla-led Serum Institute of India, and the proposed ...
- Serum Institute to invest $68 million in UK vaccine maker Oxford BiomedicaSerum Life Sciences Ltd, a unit of India-based SII, will pick up a 3.9% stake in Oxford Biomedica as part of the deal. Oxford Biomedica, sp...
- Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R&D, new vaccinesOn Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...
- Biocon Biologics to offer 15% stake to Serum Institute Life SciencesUnder the alliance, BBL will get committed access to 100 million doses of vaccines annually for 15 years and commercialisation rights of th...
- Another feather in his cap: Oxford degree for Cyrus PoonawallaPoonawalla is a philanthropist, focusing on public causes and underserved communities.
- Serum puts off plans to go publicSerum Institute of India, the Rs 1,000-crore vaccine manufacturer, has put off its plans to go public for another year.
Load More
